SCHEMBL247019

SCHEMBL247019

COc1ccc(C(=O)OC(=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.75
CA2 P00918 6/20 0.75
CES2 O00748 2/20 0.67
CES1 P23141 2/20 0.67
PARP10 Q53GL7 2/20 0.61
PARP1 P09874 1/20 0.61
PARP2 Q9UGN5 1/20 0.61
PARP4 Q9UKK3 1/20 0.61
MAPT P10636 3/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
KDM4E B2RXH2 1/20 0.58
PLK1 P53350 1/20 0.57
NR1I2 O75469 1/20 0.56
GSK3B P49841 1/20 0.55
LMNA P02545 1/20 0.55
MAPK1 P28482 1/20 0.55
RAB9A P51151 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
RXFP1 Q9HBX9 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28313267 0.98 CA1 (0.72) CA1CA2CES2CES1PARP10
SCHEMBL19795544 0.92 CA1 (0.64) CA1CA2CES2CES1PARP10
SCHEMBL247020 0.92 CES2 (0.71) CA1CA2CES2CES1PARP10
SCHEMBL10004421 0.91 CA1 (0.69) CA1CA2CES2CES1PARP10
SCHEMBL11249046 0.90 CA1 (0.62) CA1CA2CES2CES1PARP10
SCHEMBL4998485 0.89 CA1 (0.67) CA1CA2CES2CES1PARP10
SCHEMBL28586063 0.87 CA1 (0.64) CA1CA2CES2CES1PARP10
SCHEMBL27621397 0.87 CA1 (0.64) CA1CA2CES2CES1PARP10
SCHEMBL11710716 0.87 NPC1 (0.62) CA1CA2CES2CES1PARP10
SCHEMBL11710709 0.87 NPC1 (0.62) CA1CA2CES2CES1PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710422-B1 PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES SYNGENTA CROP PROTECTION AG (CH) 2026-01-07 EP claimed
WO-2025127386-A1 AMMONIUM SALT CATALYST FOR PRODUCING MODIFIED NATURAL OIL AND METHOD FOR PRODUCING MODIFIED NATURAL OIL USING SAME 한국화학연구원 2025-06-19 WO claimed
CN-119823375-A Green solid-phase synthesis method of polyarylether covalent organic framework material 南开大学 2025-04-15 CN claimed
CN-119219875-A Vinyl porous organic polymer and preparation method thereof 南开大学 2024-12-31 CN claimed
CN-119039550-A Vinyl high-crystallinity covalent organic framework film, film sensor, preparation method and application thereof 南开大学 2024-11-29 CN claimed
CN-114031639-B Preparation method of biphospide with P-O-C-P structure 烟台大学 2024-07-12 CN claimed
CN-117659577-A High-temperature-resistant ethylene propylene diene monomer rubber sealing ring and preparation method thereof 河北友联橡胶制品有限公司 2024-03-08 CN claimed
US-20240001712-A1 Tire tread composition comprising modified natural oil-based process oil and tire tread manufactured using the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2024-01-04 US claimed
CN-117003740-A Synthesis method of 1N-methyl pseudouridine derivative 江苏申基生物科技有限公司 2023-11-07 CN claimed
CN-111417618-B Process for preparing enantiomerically and diastereomerically enriched cyclobutane amines and amides 先正达参股股份有限公司 2023-06-30 CN claimed
CN-114031639-A Preparation method of biphosphonate with P-O-C-P structure 烟台大学 2022-02-11 CN claimed
CN-111417618-A Process for preparing enantiomerically and diastereomerically enriched cyclobutaneamines and cyclobutaneamides 先正达参股股份有限公司 2020-07-14 CN claimed
CN-106068271-B 2 '-substituted-2, 2' -dehydrated uridine or 2 '-substituted-2, 2' -dehydrated cytidine compound and preparation method and application thereof 张容霞 2020-03-10 CN claimed
US-20180273819-A1 THERMAL ENERGY STORAGE PHASE AND TEMPERATURE STABILIZATION CHANGE MATERIALS COMPRISING TRIAMINES AND METHODS FOR MAKING AND USING THEM ENTROPY SOLUTIONS LLC (US) 2018-09-27 US claimed
EP-2305402-B1 METHOD FOR PRODUCING SILVER-CONTAINING POWDER AND CONDUCTIVE PASTE USING THE SAME DAINIPPON INK & CHEMICALS (JP) 2017-11-29 EP claimed
WO-2016179028-A1 THERMAL ENERGY STORAGE PHASE AND TEMPERATURE STABILIZATION CHANGE MATERIALS AND METHODS FOR MAKING AND USING THEM ENTROPY SOLUTIONS, LLC. (US) 2016-11-10 WO claimed
EP-0239194-A2 Methods for preparing hydroxy compounds and intermediates SYMBICOM AB (SE) 1987-09-30 EP claimed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
US-3970671-A XANTHENE, PRESSURE SENSITIVE KANZAKI PAPER MANUFACTURING CO., LTD. (JA) 1976-07-20 US disclosed
US-3947471-A CHROMOGENIC SUMITOMO CHEMICAL COMPANY, LTD. (JA) 1976-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same ASH2L, OLA1, ODC1 CA1 167/4885CA2 32/4885CES2 2389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.